US 11274101
Heterocyclic compound
granted A61KA61K31/424A61K9/2013
Quick answer
US patent 11274101 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/424, A61K9/2013, A61K9/2018, A61K9/2054